12. Unique Considerations for Biopharmaceutics

  1. Mitchell N. Cayen
  1. Laura P. Andrews1 and
  2. James D. Green2

Published Online: 3 AUG 2010

DOI: 10.1002/9780470613191.ch12

Early Drug Development

Early Drug Development

How to Cite

Andrews, L. P. and Green, J. D. (2010) Unique Considerations for Biopharmaceutics, in Early Drug Development (ed M. N. Cayen), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470613191.ch12

Editor Information

  1. Cayen Pharmaceutical Consulting, LLC, Bedminster, New Jersey, USA

Author Information

  1. 1

    Genzyme Corporation, Framingham, Massachusetts, USA

  2. 2

    Biogen Idec, Inc., Cambridge, Massachusetts, USA

Publication History

  1. Published Online: 3 AUG 2010
  2. Published Print: 23 JUL 2010

ISBN Information

Print ISBN: 9780470170861

Online ISBN: 9780470613191

SEARCH

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
    http://wiley.force.com/Interface/ContactJournalCustomerServices_V2.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Chapter for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >